1. Home
  2. GBX vs ANIP Comparison

GBX vs ANIP Comparison

Compare GBX & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBX
  • ANIP
  • Stock Information
  • Founded
  • GBX 1974
  • ANIP 2001
  • Country
  • GBX United States
  • ANIP United States
  • Employees
  • GBX N/A
  • ANIP N/A
  • Industry
  • GBX Railroads
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • GBX Industrials
  • ANIP Health Care
  • Exchange
  • GBX Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • GBX 1.8B
  • ANIP 1.5B
  • IPO Year
  • GBX N/A
  • ANIP N/A
  • Fundamental
  • Price
  • GBX $44.36
  • ANIP $66.30
  • Analyst Decision
  • GBX Hold
  • ANIP Strong Buy
  • Analyst Count
  • GBX 2
  • ANIP 8
  • Target Price
  • GBX $57.00
  • ANIP $80.13
  • AVG Volume (30 Days)
  • GBX 464.3K
  • ANIP 393.1K
  • Earning Date
  • GBX 07-07-2025
  • ANIP 05-09-2025
  • Dividend Yield
  • GBX 2.86%
  • ANIP N/A
  • EPS Growth
  • GBX 85.75
  • ANIP N/A
  • EPS
  • GBX 6.26
  • ANIP N/A
  • Revenue
  • GBX $3,511,200,000.00
  • ANIP $674,068,000.00
  • Revenue This Year
  • GBX N/A
  • ANIP $27.68
  • Revenue Next Year
  • GBX N/A
  • ANIP $7.74
  • P/E Ratio
  • GBX $7.14
  • ANIP N/A
  • Revenue Growth
  • GBX N/A
  • ANIP 30.27
  • 52 Week Low
  • GBX $37.77
  • ANIP $52.50
  • 52 Week High
  • GBX $71.06
  • ANIP $73.72
  • Technical
  • Relative Strength Index (RSI)
  • GBX 48.25
  • ANIP 42.24
  • Support Level
  • GBX $42.49
  • ANIP $68.50
  • Resistance Level
  • GBX $45.27
  • ANIP $73.72
  • Average True Range (ATR)
  • GBX 1.21
  • ANIP 2.96
  • MACD
  • GBX 0.69
  • ANIP -0.43
  • Stochastic Oscillator
  • GBX 77.25
  • ANIP 3.08

About GBX Greenbrier Companies Inc. (The)

Greenbrier Companies Inc designs, manufactures, and markets railroad freight car equipment in North America and Europe, marine barges in North America and provides wheel services, railcar refurbishment, and parts, leasing and other services to the railroad. Its segments include Manufacturing, Maintenance Services and Leasing & Management Services. The company generates a majority of its revenue from the manufacturing segment. Geographically, it derives a majority of revenue from the United States.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: